10,381 Shares in Haleon plc (NYSE:HLN) Purchased by PFW Advisors LLC

PFW Advisors LLC acquired a new stake in shares of Haleon plc (NYSE:HLN) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 10,381 shares of the company’s stock, valued at approximately $99,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Fortitude Family Office LLC bought a new stake in shares of Haleon in the third quarter worth $28,000. Versant Capital Management Inc increased its position in shares of Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after purchasing an additional 3,348 shares during the last quarter. Toronto Dominion Bank raised its stake in shares of Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after purchasing an additional 3,470 shares in the last quarter. Prospera Private Wealth LLC bought a new position in shares of Haleon during the third quarter worth about $57,000. Finally, BOKF NA grew its stake in Haleon by 68.8% in the second quarter. BOKF NA now owns 6,972 shares of the company’s stock worth $58,000 after purchasing an additional 2,842 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. UBS Group raised shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Finally, Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Price Performance

Shares of NYSE HLN remained flat at $9.10 during midday trading on Monday. The stock had a trading volume of 8,323,355 shares, compared to its average volume of 8,433,797. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market cap of $41.19 billion, a price-to-earnings ratio of 26.76, a P/E/G ratio of 2.95 and a beta of 0.29. The business’s fifty day moving average is $9.59 and its 200 day moving average is $9.69. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.